Brain Tumors: An Interdisciplinary Approach

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital.  Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,500 scientific papers in the international journals.

• Interdisciplinary Approach in Neurological Cancers.- The Immunology of Brain Tumors.- Inherited Genetics Syndromes Associated with Central Nervous System Tumors.- Ihe Impact of Epigenetic Methylation on Gliomagenesis: An Understanding and Therapeutic Approaches.- Precision Medicine in Brain Tumors: New Approaches.- Neurosurgical Management of Malignancy: The Role of Biopsy and Resection.- Radiosurgery in the Treatment of Primary Brain Neoplasms.- Intraoperative Techniques for Imaging-Guided Surgery of Glioma.- Novel Approaches to Bypassing the Blood-Brain Barrier for Drug Delivery to Brain Tumors.- Crossing Blood Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors.- The Evolving Landscape of Monocyte/Macrophage System in Glioma.- The Link Between Excitotoxicity and Glioblastoma Multiforme.- Pediatric Low-Grade Gliomas: “Ta panta rhei”.- Pediatric Infratentorial Tumors’ Treatment in the Molecular Era.- Immunotherapeutic Strategies for Glioma Treatment.- Glioblastoma Antigen Expression for Tumor Targeting.- Unleashing the Potential of Natural Killer Cells in Immunotherapy for Glioblastoma and Brain Tumors.- Mechanisms of Chemoresistance in High-Grade Gliomas.- Cancer-Related Stroke. A Narrative Review About Pathomechanisms, Epidemiology and Neuroimaging Issues.- Potential Role of Artificial Intelligence in the Treatment of Glioblastoma in Children and Adults.